What is it about?

Lymphopenia and immune dysfunction in COVID-19 is increasingly recognized and studied. This case report details a secondary infection following lymphopenia with CD4+ count drop in a COVID-19 patient with no history of immunosuppression or infection with HIV. The mechanism of lymphopenia, both CD4+ and CD8+ T cell count drops, in COVID-19 needs further study.

Featured Image

Why is it important?

The literature has shown that COVID-19 patients commonly have lymphopenia, a decrease in CD4+ and/or CD8+ T cells, that may increase susceptibility to secondary bacterial infection. Here, we report a secondary pneumonia in a non-HIV COVID-19 patient with new CD4+ T cell depletion.

Perspectives

As of now, the mechanism of lymphopenia, both CD4+ and CD8+ T cell count drops, in COVID-19 needs further study. Firstly, lymphopenia may be caused by increased cell death. An interesting study performed a transcriptomic RNA-sequencing analysis in COVID-19 patients with lymphopenia and found that apoptosis and p53 cell death pathways were activated in lymphocytes of COVID-19 patients when compared to healthy individuals.2 Secondly, cytokines or hypercytokinemia may play a role in lymphopenia in COVID-19. Proinflammatory cytokines such as TNF-alpha have been shown to cause lymphopenia by suppressing hematopoiesis.3 Also, SARS-CoV-2 virus may be capable of entering T lymphocytes by binding to a T cell surface protein such as CD147 and may cause a direct cytopathic effect to lymphocytes.4 Other possible mechanisms of lymphopenia in COVID-19 that need further study include lymphocyte exhaustion, possible bone marrow suppression by cytokines, or sequestration of lymphocytes in the lung with extensive infection.3, 4 References

Dr. Le Huu Nhat Minh
Taipei Medical University

Read the Original

This page is a summary of: COVID-19 induced immunosuppression leading to secondary infection in a non-HIV patient, Minerva Respiratory Medicine, May 2021, Edizioni Minerva Medica,
DOI: 10.23736/s2784-8477.21.01914-3.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page